Transcutaneous Posterior Tibial Nerve Stimulation: An Adjuvant Treatment for Intractable Constipation in Children

• Published in: Biomedicines Vol. 12; no. 1; p. 164
• Main Authors: Rego, Rebeca Mayara Padilha, Machado, Nilton Carlos, Carvalho, Mary de Assis, Graffunder, Johann Souza, Fraguas, Crhistiano, Ortolan, Erika Veruska Paiva, Lourenção, Pedro Luiz Toledo de Arruda
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.01.2024
• Subjects: Adjuvant therapy; adolescent; Adolescents; Ankle; Care and treatment; child; Children; Constipation; Defecation; Electrical stimuli; Electrodes; Fecal incontinence; Feces; Health aspects; Intervention; Intestine; Nerves; Neuromodulation; Pain; Parents & parenting; Patient compliance; Patients; Pediatrics; Quality of life; Questionnaires; Sacrum; Sennosides; Silicones; Teenagers; Tibial nerve; transcutaneous electric nerve stimulation; Brazil; constipation; adolescent; transcutaneous electric nerve stimulation; child
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines12010164

Functional constipation can lead to painful defecations, fecal incontinence, and abdominal pain, significantly affecting a child's quality of life. Treatment options include non-pharmacological and pharmacological approaches, but some cases are intractable and require alternative interventions like neuromodulation. A subtype of neuromodulation, called Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS), comprises electrical stimulation at the ankle level, by means of electrodes fixed to the skin. TPTNS is a minimally invasive, easy-to-apply technique that can potentially improve constipation symptoms in the pediatric population by stimulating the sacral nerves. To evaluate the clinical results and applicability of TPTNS as an adjuvant treatment for children and adolescents with functional constipation. Between April 2019 and October 2021, 36 patients diagnosed with functional constipation according to the Rome IV Criteria were invited to participate in the study. The study followed a single-center, uncontrolled, prospective cohort design. Patients received TPTNS for 4 or 8 weeks, with assessments conducted immediately after the periods of TPTNS and 4 weeks after the end of the intervention period. The data normality distribution was determined by the Shapiro-Wilk test. The Wilcoxon test and Student's -test for paired samples were used to compare quantitative variables, and the McNemar test was used to compare categorical variables. Of the 36 enrolled patients, 28 children and adolescents with intractable function constipation completed the study, receiving TPTNS for 4 weeks. Sixteen patients (57.1%) extended the intervention period for 4 extra weeks, receiving 8 weeks of intervention. TPTNS led to significant improvements in stool consistency, frequency of defecation, and bowel function scores, with a reduction in abdominal pain. Quality of life across physical and psychosocial domains showed substantial enhancements. The quality of life-related to bowel habits also improved significantly, particularly in lifestyle, behavior, and embarrassment domains. The positive effects of this intervention are seen relatively early, detected after 4 weeks of intervention, and even 4 weeks after the end of the intervention. TPTNS was well-tolerated, with an adherence rate of approximately 78%, and no adverse effects were reported. TPTNS is an adjuvant treatment for intractable functional constipation, improving bowel function and quality of life. The effects of TPTNS were observed relatively early and sustained even after treatment cessation.